Levitee Labs Inc. Stock Analysis LVT.CN

Levitee Labs, Inc. engages in the development and sale of high potency mushroom extract nutraceuticals and supplies and equipment for mushroom cultivation. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-07-21. The firm focuses on integrative wellness space. Through integrating evidence-based complementary medicines into the traditional infrastructure of mental health and addiction services, Levitee aims to transform mental health and addiction treatments. The Company’s current portfolio of assets include: Levitee Clinics, a group of approximately five operating addiction and pain treatment clinics in Alberta; Levitee Pharmacies, approximately three pharmacies operating in Alberta specialized in filling prescriptions for patients with substance-use disorders, mental health conditions, and chronic pain; BlockMD, the technology Company in Alberta to receive provincial approval for electronic-prescriptions in the addiction treatment space; and Earth Circle Organics, a direct-to-consumer and wholesaler of supplements and superfood products with 180+ SKUs in its products.